Tesamorelin 6mg + Ipamorelin 2mg Research Blend
This research blend combines Tesamorelin 6mg and Ipamorelin 2mg in a single lyophilized vial at greater than 98% purity per component, third-party tested with a certificate of analysis and manufactured in the USA. It is sold strictly as a research chemical for in-vitro and laboratory use by qualified professionals.
Blend Composition
Tesamorelin: 6mg Ipamorelin: 2mg Total peptide content: 8mg per vial
Component Mechanisms
Tesamorelin is a stabilized growth-hormone-releasing hormone (GHRH) analog that binds the GHRH receptor on pituitary somatotroph cells in research models. Ipamorelin is a selective secretagogue that acts on the ghrelin/GHS receptor. These components are combined so laboratories can study their receptor-signaling dynamics together in a single preparation.
Research Applications
This blend is used as an investigational tool in secretagogue and GHRH-receptor research. The single-compound vials are also available: Tesamorelin and Ipamorelin. Reconstitution requires bacteriostatic water.
Related Blends
Peptides Source offers several Tesamorelin blend ratios so laboratories can match composition to protocol: Tesamorelin 13mg + Ipamorelin 3mg, Tesamorelin 5mg + Ipamorelin 5mg, Tesamorelin 10mg + Ipamorelin 5mg, Tesamorelin 6mg + Ipamorelin 3mg + CJC-1295 3mg.
Protocol & Handling
Reconstitute the lyophilized powder with bacteriostatic water to the concentration required by the study protocol. Store the sealed lyophilized vial at -20°C; once reconstituted, keep it refrigerated at 2 to 8°C and protect it from repeated freeze-thaw cycles. All handling should follow standard laboratory safety practice. These parameters describe in-vitro handling only.
Specifications
Compounds: Tesamorelin 6mg and Ipamorelin 2mg Total peptide content: 8mg per vial Purity: greater than 98% per component (third-party tested, COA available) Physical form: lyophilized powder Origin: manufactured in the USA Classification: research use only
Tesamorelin 6mg + Ipamorelin 2mg Frequently Asked Questions
What is in this Tesamorelin blend?
This vial contains Tesamorelin 6mg and Ipamorelin 2mg, for a total of 8mg of peptide. Each component is third-party tested to greater than 98% purity.
How do the components work in research models?
Tesamorelin binds the GHRH receptor and Ipamorelin acts on the ghrelin/GHS receptor. In research models these pathways are studied for their combined signaling dynamics. All findings are from in-vitro and animal systems.
What purity is this blend?
Every component is third-party tested to greater than 98% purity, with a certificate of analysis available. The blend is manufactured in the USA and supplied as a lyophilized powder.
How is the blend reconstituted and stored?
Reconstitute the lyophilized powder with bacteriostatic water to the desired research concentration. Store the sealed vial at -20°C and keep reconstituted material refrigerated at 2 to 8°C, avoiding repeated freeze-thaw cycles.
Why use a blend instead of single peptides?
Pre-combined blends let laboratories study multiple secretagogue pathways from a single preparation at fixed ratios. Single-compound Tesamorelin and Ipamorelin vials are also available for separate protocols.
Is this blend for human use?
No. It is sold strictly as a research chemical for laboratory and in-vitro use by qualified professionals. It is not for human or animal consumption.
Research Use Only
All products supplied by Peptides Source are intended for laboratory research and in-vitro use only. They are not drugs, foods, or cosmetics, are not intended to diagnose, treat, cure, or prevent any disease or condition, and are not for human or animal consumption.